SCHEMBL7746639

SCHEMBL7746639

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1c(Cl)cccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.61
FLT1 P17948 1/20 0.61
FLT4 P35916 1/20 0.61
PTGS2 P35354 1/20 0.43
KDM4E B2RXH2 1/20 0.43
APOBEC3A P31941 1/20 0.43
GFER P55789 1/20 0.43
HDAC1 Q13547 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
SMO Q99835 2/20 0.42
AGPAT2 O15120 1/20 0.41
ALOX15 P16050 1/20 0.40
HSP90AA1 P07900 1/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744662 0.92 KDR (0.61) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7744663 0.89 KDR (0.76) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7739078 0.88 KDR (0.68) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7739068 0.88 KDR (0.47) KDRFLT1FLT4PTGS2HDAC1
SCHEMBL7739087 0.88 KDR (0.69) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7744175 0.87 KDR (0.49) KDRFLT1FLT4MAPTSMN1; SMN2
SCHEMBL7744041 0.85 HPGD (0.46) KDRFLT1FLT4PTGS2KDM4E
SCHEMBL7746642 0.83 KDR (0.55) KDRFLT1FLT4SMOALOX15
SCHEMBL7739015 0.82 KDR (0.68) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7739014 0.82 KDR (0.63) KDRFLT1FLT4KDM4EAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed